1. Home
  2. DTCK vs MRNS Comparison

DTCK vs MRNS Comparison

Compare DTCK & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTCK
  • MRNS
  • Stock Information
  • Founded
  • DTCK 1999
  • MRNS 2003
  • Country
  • DTCK Singapore
  • MRNS United States
  • Employees
  • DTCK N/A
  • MRNS N/A
  • Industry
  • DTCK Farming/Seeds/Milling
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • DTCK Industrials
  • MRNS Health Care
  • Exchange
  • DTCK Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • DTCK 26.5M
  • MRNS 29.9M
  • IPO Year
  • DTCK 2023
  • MRNS 2014
  • Fundamental
  • Price
  • DTCK $1.08
  • MRNS $0.54
  • Analyst Decision
  • DTCK
  • MRNS Buy
  • Analyst Count
  • DTCK 0
  • MRNS 12
  • Target Price
  • DTCK N/A
  • MRNS $4.28
  • AVG Volume (30 Days)
  • DTCK 91.4K
  • MRNS 3.2M
  • Earning Date
  • DTCK 11-13-2024
  • MRNS 03-04-2025
  • Dividend Yield
  • DTCK N/A
  • MRNS N/A
  • EPS Growth
  • DTCK N/A
  • MRNS N/A
  • EPS
  • DTCK 0.02
  • MRNS N/A
  • Revenue
  • DTCK $159,836,000.00
  • MRNS $31,466,000.00
  • Revenue This Year
  • DTCK N/A
  • MRNS $14.97
  • Revenue Next Year
  • DTCK N/A
  • MRNS $57.65
  • P/E Ratio
  • DTCK $59.03
  • MRNS N/A
  • Revenue Growth
  • DTCK N/A
  • MRNS 1.63
  • 52 Week Low
  • DTCK $0.80
  • MRNS $0.22
  • 52 Week High
  • DTCK $1.75
  • MRNS $10.50
  • Technical
  • Relative Strength Index (RSI)
  • DTCK 50.49
  • MRNS 70.92
  • Support Level
  • DTCK $1.04
  • MRNS $0.53
  • Resistance Level
  • DTCK $1.17
  • MRNS $0.55
  • Average True Range (ATR)
  • DTCK 0.09
  • MRNS 0.01
  • MACD
  • DTCK -0.00
  • MRNS 0.01
  • Stochastic Oscillator
  • DTCK 59.14
  • MRNS 65.43

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: